30 September 2021 | News
Offering more than 230 tests across disease areas
Roche Diagnostics India has announced the launch of cobas pure integrated solutions analyzer with a more intelligent system particularly suitable for a large number of labs and hospitals operating in India, to make better use of their space and expand their offering of high medical value tests for the benefit of patients.
This new compact analyzer combines clinical chemistry, immunoassay, and Ion Concentration Measurement (ISE) diagnostic testing on a single platform helping labs simplify daily operations with limited space and resources. Cobas pure analyzer offers the longest onboard stability of reagents allowing labs to expand their test menu.
Built on the latest technology, cobas pure integrated solutions analyzer provides labs with an integrated system that focuses on the automation of manual tasks. This reduces the hands-on maintenance time of technicians to just 5 minutes per day which is 80 percent less than previous generation systems.iv v vi vii This will help improve the productivity of lab personnel whilst also enabling faster delivery of test results and clinical decision-making.
With a footprint of just two square meters, cobas pure analyzer is smaller than previous generation systems. It is able to perform up to 870 tests per hour whilst providing medium-sized labs with access to the full clinical chemistry and immunochemistry assay menu from Roche which includes more than 230 diagnostic tests across a wide range of disease areas such as critical care, infectious diseases including COVID-19, Women’s Health, Oncology, Cardiology, Endocrinology and TDM (Therapeutic Drug Monitoring).